
You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Advertising (2) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (2) Apply Biologicals filter
- Remove Complementary medicines filter Complementary medicines (7)
- Remove Disinfectants/Sterilants filter Disinfectants/Sterilants (0)
- Fees/Payments (1) Apply Fees/Payments filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (1) Apply Labelling/Packaging filter
- Legislation (3) Apply Legislation filter
- Listed medicines (2) Apply Listed medicines filter
- Manufacturing (1) Apply Manufacturing filter
- Remove Medical devices/IVDs filter Medical devices/IVDs (55)
- Remove Medical devices safety filter Medical devices safety (1)
- Remove Medicinal cannabis filter Medicinal cannabis (1)
- Medicines (2) Apply Medicines filter
- Medicines safety (1) Apply Medicines safety filter
- OTC medicines (12) Apply OTC medicines filter
- Other therapeutic goods (1) Apply Other therapeutic goods filter
- Prescription medicines (6) Apply Prescription medicines filter
- Scheduling (56) Apply Scheduling filter
- Therapeutic Goods Administration (TGA) (2) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (2) Apply Therapeutic goods regulation filter
- (-) Remove Medicinal cannabis filter Medicinal cannabis
- (-) Remove Disinfectants/Sterilants filter Disinfectants/Sterilants
- (-) Remove Complementary medicines filter Complementary medicines
- (-) Remove Medical devices safety filter Medical devices safety
- (-) Remove Medical devices/IVDs filter Medical devices/IVDs
Proposed regulatory options for medical devices containing nanomaterials
Closed on 9 April 2021
Proposal to remove redundant processes for entering certain formulation information into a therapeutic goods application
Closed on 24 February 2021
Australian Medical Device Regulations definition of Central Circulatory System (CCS)
Closed on 10 February 2021
Potential reforms to medicinal cannabis manufacturing, labelling and packaging requirement
Closed on 29 January 2021
Exploring options for the introduction of an Australian Unique Device Identification (UDI) System
Closed on 24 December 2020
IMDRF consultation: Proposed update to document on Post-Market Clinical Follow-Up Studies
Closed on 11 December 2020
Proposed enhancements to adverse event reporting for medical devices
Closed on 2 December 2020
IMDRF consultation: Competence and Training Requirements for Regulatory Authority Assessors of Conformity Assessment Bodies
Closed on 26 May 2020
Scope of Regulated Software based products
Closed on 13 May 2020